Dynavax Technologies Stock Analysis

DVAX Stock  USD 11.42  0.34  2.89%   
Dynavax Technologies is undervalued with Real Value of 14.81 and Target Price of 24.5. The main objective of Dynavax Technologies stock analysis is to determine its intrinsic value, which is an estimate of what Dynavax Technologies is worth, separate from its market price. There are two main types of Dynavax Technologies' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Dynavax Technologies' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Dynavax Technologies' stock to identify patterns and trends that may indicate its future price movements.
The Dynavax Technologies stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Dynavax Technologies is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Dynavax Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Dynavax Technologies' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Dynavax Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The book value of Dynavax Technologies was currently reported as 4.8. The company recorded a loss per share of 0.05. Dynavax Technologies had not issued any dividends in recent years. The entity had 1:10 split on the 10th of November 2014. Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Dynavax Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 311 people. To learn more about Dynavax Technologies call Eddie Gray at 510 848 5100 or check out https://www.dynavax.com.

Dynavax Technologies Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Dynavax Technologies' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Dynavax Technologies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Dynavax Technologies generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 232.28 M. Net Loss for the year was (6.39 M) with profit before overhead, payroll, taxes, and interest of 448.22 M.
Dynavax Technologies has a frail financial position based on the latest SEC disclosures
Over 98.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Global Vaccine Adjuvants Market Size To Worth USD 1.51 Billion By 2033 CAGR of 3.9

Dynavax Technologies Upcoming and Recent Events

Earnings reports are used by Dynavax Technologies to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Dynavax Technologies previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Dynavax Largest EPS Surprises

Earnings surprises can significantly impact Dynavax Technologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-22
2023-12-31-0.010.00160.0116116 
2021-05-06
2021-03-31-0.020.010.03150 
2023-05-02
2023-03-31-0.13-0.19-0.0646 
View All Earnings Estimates

Dynavax Technologies Thematic Classifications

In addition to having Dynavax Technologies stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Dynavax Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Dynavax Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dynavax Technologies backward and forwards among themselves. Dynavax Technologies' institutional investor refers to the entity that pools money to purchase Dynavax Technologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2023-12-31
2.5 M
Blair William & Co2023-12-31
2.4 M
Renaissance Technologies Corp2023-12-31
1.9 M
Rock Springs Capital Management Lp2023-12-31
1.7 M
Driehaus Capital Management Llc2023-12-31
1.6 M
Kynam Capital Management, Lp2023-12-31
1.5 M
Northern Trust Corp2023-12-31
1.4 M
Fisher Asset Management, Llc2023-12-31
1.4 M
Woodline Partners Lp2023-12-31
1.3 M
Blackrock Inc2023-12-31
23.4 M
Federated Hermes Inc2023-12-31
11.4 M
Note, although Dynavax Technologies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Dynavax Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dynavax Technologies's market, we take the total number of its shares issued and multiply it by Dynavax Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Dynavax Profitablity

Dynavax Technologies' profitability indicators refer to fundamental financial ratios that showcase Dynavax Technologies' ability to generate income relative to its revenue or operating costs. If, let's say, Dynavax Technologies is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Dynavax Technologies' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Dynavax Technologies' profitability requires more research than a typical breakdown of Dynavax Technologies' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.12.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.01)(0.01)
Return On Capital Employed(0.04)(0.04)
Return On Assets(0.01)(0.01)
Return On Equity(0.01)(0.01)

Management Efficiency

Dynavax Technologies has return on total asset (ROA) of (0.0192) % which means that it has lost $0.0192 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0106) %, meaning that it created substantial loss on money invested by shareholders. Dynavax Technologies' management efficiency ratios could be used to measure how well Dynavax Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.0067 in 2024. Return On Capital Employed is likely to drop to -0.04 in 2024. At this time, Dynavax Technologies' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 19.9 M in 2024, whereas Other Assets are likely to drop slightly above 3 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 4.83  5.07 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 4.82  5.06 
Enterprise Value Over EBITDA 90.87  95.41 
Price Book Value Ratio 2.89  4.48 
Enterprise Value Multiple 90.87  95.41 
Price Fair Value 2.89  4.48 
Enterprise Value356.6 M317 M
The analysis of Dynavax Technologies' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Dynavax Technologies' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Dynavax Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.282

Technical Drivers

As of the 25th of April, Dynavax Technologies shows the Variance of 2.51, mean deviation of 1.2, and Standard Deviation of 1.58. Dynavax Technologies technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze thirteen technical drivers for Dynavax Technologies, which can be compared to its peers. Please confirm Dynavax Technologies variance and potential upside to decide if Dynavax Technologies is priced favorably, providing market reflects its regular price of 11.42 per share. Given that Dynavax Technologies has information ratio of (0.22), we urge you to verify Dynavax Technologies's prevailing market performance to make sure the company can sustain itself at a future point.

Dynavax Technologies Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Dynavax Technologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Dynavax Technologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Dynavax Technologies Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dynavax Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dynavax Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dynavax Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Dynavax Technologies Predictive Daily Indicators

Dynavax Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Dynavax Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Dynavax Technologies Corporate Filings

11th of April 2024
Other Reports
ViewVerify
F3
5th of April 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
1st of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
19th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
12th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
4th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
22nd of February 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
20th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Dynavax Technologies Forecast Models

Dynavax Technologies' time-series forecasting models are one of many Dynavax Technologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dynavax Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Dynavax Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Dynavax Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Dynavax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Dynavax Technologies. By using and applying Dynavax Stock analysis, traders can create a robust methodology for identifying Dynavax entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.02)(0.02)
Operating Profit Margin(0.16)(0.17)
Net Loss(0.03)(0.03)
Gross Profit Margin 0.78  0.82 

Current Dynavax Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Dynavax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Dynavax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
24.5Strong Buy5Odds
Dynavax Technologies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Dynavax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dynavax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dynavax Technologies, talking to its executives and customers, or listening to Dynavax conference calls.
Dynavax Analyst Advice Details

Dynavax Stock Analysis Indicators

Dynavax Technologies stock analysis indicators help investors evaluate how Dynavax Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Dynavax Technologies shares will generate the highest return on investment. By understating and applying Dynavax Technologies stock analysis, traders can identify Dynavax Technologies position entry and exit signals to maximize returns.
Begin Period Cash Flow202.2 M
Total Stockholder Equity622.1 M
Capital Lease Obligations34.2 M
Total Liab375 M
Property Plant And Equipment Net61.6 M
Cash And Short Term Investments742.3 M
Cash150.3 M
50 Day M A12.3264
Net Interest Income20 M
Total Current Liabilities62.2 M
Forward Price Earnings400
Investments-166.7 M
Interest Expense6.8 M
Stock Based Compensation42.6 M
Long Term Debt222.7 M
Common Stock Shares Outstanding128.7 M
Tax Provision1.5 M
Quarterly Earnings Growth Y O Y-0.765
Other Current Assets19 M
Accounts Payable5.2 M
Net Debt106.6 M
Other Operating Expenses258 M
Non Current Assets Total138 M
Liabilities And Stockholders Equity997.1 M
Non Currrent Assets Other74.3 M
When determining whether Dynavax Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dynavax Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dynavax Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dynavax Technologies Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.
Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Dynavax Stock analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(0.05)
Revenue Per Share
1.804
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.02)
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.